H. Ümit Kanıskan
- Molecular Biology top 2%
- Protein Degradation and Inhibitors 30
- Ubiquitin and proteasome pathways 21
- Cancer-related gene regulation 14
- Epigenetics and DNA Methylation 13
- Histone Deacetylase Inhibitors Research 8
- Hematology top 5%
- Oncology top 5%
- Peptidase Inhibition and Analysis 14
- Health Informatics top 5%
- Cancer Research top 10%
-
- Asymmetric Synthesis and Catalysis 5
-
- Microbial Natural Products and Biosynthesis 4
- Cited by
- Molecular BiologyHematologyOncology
- Partner nations
- United StatesCanadaChina
In The Last Decade
H. Ümit Kanıskan
54 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 2.6k
- Hematology 336
- Oncology 767
- Health Informatics 34
- Cancer Research 184
Countries citing papers authored by H. Ümit Kanıskan
This map shows the geographic impact of H. Ümit Kanıskan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Ümit Kanıskan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Ümit Kanıskan more than expected).
Fields of papers citing papers by H. Ümit Kanıskan
This network shows the impact of papers produced by H. Ümit Kanıskan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Ümit Kanıskan. The network helps show where H. Ümit Kanıskan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. Ümit Kanıskan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 34 | |
| 12 | 2023 | 18 | |
| 13 | 2022 | 42 | |
| 14 | 2022 | 39 | |
| 15 | 2022 | 22 | |
| 16 | 2022 | 32 | |
| 17 | 2021 | 96 | |
| 18 | 2021 | 178 | |
| 19 | 2021 | 91 | |
| 20 | 2021 | 82 |
About H. Ümit Kanıskan
H. Ümit Kanıskan is a scholar working on Biological Psychiatry, Molecular Biology and Oncology, having authored 62 papers that have together received 3.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (30 papers), Ubiquitin and proteasome pathways (21 papers), Peptidase Inhibition and Analysis (14 papers), Cancer-related gene regulation (14 papers), Epigenetics and DNA Methylation (13 papers), Histone Deacetylase Inhibitors Research (8 papers), Asymmetric Synthesis and Catalysis (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). The work is most often cited by research in Molecular Biology (2.6k citations), Hematology (336 citations) and Oncology (767 citations). H. Ümit Kanıskan has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Jian Jin, Jing Liu, Wenyi Wei, Kwang‐Su Park, He Chen, Brandon Dale, Michael L. Martini, Yue Xiong, Meng Cheng and Philip Garner.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.